Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
Alkem Laboratories Limited logo

Alkem Laboratories Limited

ALKEM·Pharmaceuticals
  • Nifty 500

Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)

258Announcements
08-09-2026Last filed
29Last 90 days

What Alkem files

  • Others96
  • Investor Meet62
  • Updates42
  • Important22
  • PPTs11
  • Board Meeting11
Showing JV/Acquisition announcements (2)Clear filter
13-02-2026 · 02:01 pm

Alkem Labs' board has approved the merger of its wholly-owned subsidiary, Adroit Biomed, with itself. This move aims to integrate business operations, enhance scale, optimize costs, and simplify the corporate structure. Adroit Biomed, engaged in pharmaceuticals and nutraceuticals trading, reported ₹59.68 Cr revenue and ₹7.57 Cr net worth in FY25....

Read the full announcement→
PDF
06-02-2026 · 01:51 pm

Alkem Laboratories' subsidiary, Alkem Medtech Private (AMPL), is merging with its own wholly-owned subsidiary, Alkem Medtech Ortho Private (AMOPL). This move aims to simplify the group structure, optimize operations, reduce costs, enhance efficiency, and expand the combined entity's product portfolio. Financials (as of March 2025): AMOPL had a paid-up capital...

Read the full announcement→
PDF